TwinBeech Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TwinBeech Capital's PFE Position: Q2 2026 in Review
TwinBeech Capital increased its Pfizer (PFE) stake by 219% in Q2 2026, buying an estimated $586K and bringing the position to 32,623 shares worth $786K. The position accounts for 0.14% of the portfolio, ranked #172.
TwinBeech Capital first reported a position in PFE in Q1 2021 and has held it in 14 quarters since. The position peaked at $61.5M in Q4 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- TwinBeech Capital held 32,623 shares of Pfizer worth $786K as of Q2 2026.
- TwinBeech Capital bought 22,389 Pfizer shares in Q2 2026, an estimated $586K.
- Pfizer made up 0.14% of TwinBeech Capital's portfolio in Q2 2026, its #172 holding.
- TwinBeech Capital first reported a position in Pfizer in Q1 2021 and has held it in 14 quarters since.
- TwinBeech Capital's Pfizer position peaked at $61.5M in Q4 2024.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.